Numab Therapeutics and Kaken Pharmaceutical Enter Collaborationand Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease
Numab to receive R&D funding for the preclinical development of ND081 Kaken…
AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency
Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress…
Aino Health AB (publ): interim report january-september 2024
This document in English is a translation of the original in Swedish.…
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024
COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced…
NINER Pharmaceutical Strengthens Global Presence with Strategic IV Fluid Supply Initiative for the U.S. and Latin American Markets
DUBAI, United Arab Emirates, Nov. 15, 2024 (GLOBE NEWSWIRE) -- NINER Pharmaceutical,…
Jeffrey Triganza Joins Harbour Investment Partners as Director, Bringing Extensive Financial Expertise
Sydney, AU, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Harbour Investment Partners is…
Draper Associates Backs Torram to Propel Decentralized Finance on Bitcoin
Toronto, Canada, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Torram, pioneering institutional-grade decentralized…
KRAET – Bridging the Asset-Blockchain Gap
Singapore, Nov. 14, 2024 (GLOBE NEWSWIRE) -- In recent years, blockchain technology…
WH Alliance: Roland Quisenberry and AI ProfitPulse Drive the Future of Financial Education and Investment Innovation
Dallas, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- WH Alliance proudly announces…
Revolutionizing Social Media: How Avatar Social Combines Blockchain and AI for a Unified Experience
Singapore, Nov. 14, 2024 (GLOBE NEWSWIRE) -- What is AVATAR and what…
